Michael F. Mahoney

2019

In 2019, Michael F. Mahoney earned a total compensation of $15.8M as Chairman of the Board, President and Chief Executive Officer at Boston Scientific, a 13% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$409,290
Non-Equity Incentive Plan$1,996,800
Option Awards$2,699,992
Salary$1,274,740
Stock Awards$9,087,249
Other$296,069
Total$15,764,140

Mahoney received $9.1M in stock awards, accounting for 58% of the total pay in 2019.

Mahoney also received $409.3K of change in pension value and nonqualified deferred compensation earnings, $2M in non-equity incentive plan, $2.7M in option awards, $1.3M in salary and $296.1K in other compensation.

Rankings

In 2019, Michael F. Mahoney's compensation ranked 308th out of 13,971 executives tracked by ExecPay. In other words, Mahoney earned more than 97.8% of executives.

ClassificationRankingPercentile
All
308
out of 13,971
98th
Division
Manufacturing
107
out of 5,692
98th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
14
out of 832
98th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
6
out of 535
99th
Industry
Surgical and Medical Instruments and Apparatus
3
out of 350
99th

Pay ratio

Michael F. Mahoney's Pay$15,764,140
Median Employee's Pay$65,630
Pay Ratio

240

to 1

In 2019, the annual total compensation of Michael F. Mahoney was $15,764,140.

The annual total compensation of the median employee at Boston Scientific was $65,630.

The ratio of Michael F. Mahoney's pay to the pay of median employee was therefore 240 to one.

Source: SEC filing on March 25, 2020.

Mahoney's colleagues

We found four more compensation records of executives who worked with Michael F. Mahoney at Boston Scientific in 2019.

2019

Daniel Brennan

Boston Scientific

Chief Financial Officer

2019

Joseph Fitzgerald

Boston Scientific

Executive Vice President and President, Rhythm Management

2019

Kevin Ballinger

Boston Scientific

Executive Vice President and President, Interventional Cardiology

2019

Edward Mackey

Boston Scientific

Executive Vice President, Operations

News

You may also like